We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+6.99%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.36B
AUM Growth
+$242M
Cap. Flow
+$106M
Cap. Flow %
4.48%
Top 10 Hldgs %
34.74%
Holding
3,215
New
294
Increased
1,348
Reduced
581
Closed
158

Sector Composition

Rank Sector Weight
1 Technology 15.92%
2 Financials 7.56%
3 Healthcare 5.92%
4 Communication Services 5.21%
5 Consumer Discretionary 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRP icon
2501
Invesco Variable Rate Preferred ETF
VRP
$3.02B
$3K ﹤0.01%
111
VSH icon
2502
Vishay Intertechnology
VSH
$5.43B
$3K ﹤0.01%
140
-23
-14% -$552
VTVT icon
2503
vTv Therapeutics
VTVT
$139M
$3K ﹤0.01%
38
WD icon
2504
Walker & Dunlop
WD
$1.53B
$3K ﹤0.01%
32
XRX icon
2505
Xerox
XRX
$425M
$3K ﹤0.01%
109
+61
+127% +$1.48K
YYY icon
2506
Amplify CEF High Income ETF
YYY
$741M
$3K ﹤0.01%
145
NEUE
2507
DELISTED
NeueHealth
NEUE
$3K ﹤0.01%
+3
New +$4.11K
TBCH
2508
Turtle Beach Corp
TBCH
$277M
$3K ﹤0.01%
102
CDMO
2509
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$3K ﹤0.01%
+110
New +$2.35K
TARO
2510
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$3K ﹤0.01%
38
BTWN
2511
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
$3K ﹤0.01%
300
-427
-59% -$4.43K
MNTV
2512
DELISTED
Momentive Global Inc. Common Stock
MNTV
$3K ﹤0.01%
123
FEO
2513
DELISTED
First Trust/abrdn Emerging Opportunity Fund
FEO
$3K ﹤0.01%
203
SRSA
2514
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
$3K ﹤0.01%
300
MNR
2515
DELISTED
Monmouth Real Estate Investment Corp
MNR
$3K ﹤0.01%
+138
New +$2.59K
ABUS icon
2516
Arbutus Biopharma
ABUS
$915M
$2K ﹤0.01%
550
ACRS icon
2517
Aclaris Therapeutics
ACRS
$869M
$2K ﹤0.01%
100
-1,100
-92% -$25K
ADEA icon
2518
Adeia
ADEA
$3.11B
$2K ﹤0.01%
291
AG icon
2519
First Majestic Silver
AG
$9.07B
$2K ﹤0.01%
115
-267
-70% -$4.45K
AGEN
2520
Agenus
AGEN
$290M
$2K ﹤0.01%
21
AMWD
2521
DELISTED
American Woodmark
AMWD
$2K ﹤0.01%
26
API
2522
Agora
API
$377M
$2K ﹤0.01%
50
ASMB icon
2523
Assembly Biosciences
ASMB
$529M
$2K ﹤0.01%
+40
New +$1.98K
ATEX icon
2524
Anterix
ATEX
$1.94B
$2K ﹤0.01%
37
AUB icon
2525
Atlantic Union Bankshares
AUB
$5.97B
$2K ﹤0.01%
56
-12
-18% -$471

Similar funds

Parallel Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Parallel Advisors held 3,215 positions worth $2.36B, up 11% from $2.12B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parallel Advisors deployed $106M of net new capital in Q2 2021, opening 294 new positions and adding to 1,348 existing holdings. Its largest new stake was Dimensional US Core Equity 2 ETF: 118,367 shares worth $3.19M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares US Treasury Bond ETF, an estimated $8.53M trimmed.

  • Parallel Advisors's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 118,367 shares worth $3.19M.
  • Parallel Advisors added most to State Street Energy Select Sector SPDR ETF in Q2 2021, an estimated $14.3M increase.
  • Parallel Advisors's biggest Q2 2021 reduction was iShares US Treasury Bond ETF, cutting an estimated $8.53M.
  • Parallel Advisors fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $365K.
  • Parallel Advisors's ten largest holdings make up 35% of its $2.36B portfolio in Q2 2021.
  • Parallel Advisors opened 294 new positions and closed 158 in Q2 2021.
  • Parallel Advisors's portfolio value rose 11% quarter-over-quarter to $2.36B.

Based on Parallel Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.